We guide pharmaceutical development by revealing pharmacodynamics in complex biological processes and find novel therapeutic interventions.

He is the Co-Founder and CEO of Mesh Bio, a Southeast Asia’s leading deep healthtech startup focused on providing predictive analytics solutions based on foundational digital twin models, for chronic disease diagnosis and management.

Jan 30, 2024 · Mesh Bio has raised US$3.5 million in Series A financing led by East Ventures, a pioneering and leading sector-agnostic venture capital firm focusing on Southeast Asia.

BEST PRACTICE AND ACTIONABLE RECOMMENDATIONS. Clinical and lifestyle recommendations engine covering thousands of medical scenarios, can be customized to direct patients to targeted care and wellness services.

The latest news about Mesh Bio, a digital health startup that uses predictive analytics for the management of chronic diseases.

Mesh Bio develops clinical decision support analytics and automation solutions for management of chronic disease, such as cardiovascular disease. These solutions enable data driven care …

Oct 26, 2023 · The company's flagship product, HealthVector Diabetes (HVD), is the world's first digital twin approved for clinical use, predicting chronic kidney disease (CKD) risk in Type 2 diabetes patients. Mesh Bio's collaboration with leading healthcare institutions further solidifies its commitment to driving innovation and improving patient outcomes. ‍

Singapore-based Mesh Bio, a digital health startup transforming chronic disease management through predictive analytics, and UK-based artificial intelligence (AI)-enabled drug discovery company MultiOmic Health today announce their partnership to conduct an observational clinical study on patients with chronic metabolic disease and increased ...

Singapore-based healthtech startup Mesh Bio has raised USD1.8 million (SGD2.4 million) in Seed funding, led by deep tech investors Elev8.vc and Enterprise Singapore’s investment arm Seeds Capital, along with Citrine Capital and Tael Partners.

SINGAPORE, 17 March 2023, Singapore-based Mesh Bio, a digital health deep tech startup transforming chronic disease management through predictive analytics, and leading diagnostics services provider in Indonesia, PT Pramita (Pramita) today announced a regional partnership to deliver predictive analytics-powered medical check-ups and preventive ...